Fiji vs Vanuatu: Cause of death, by non-communicable diseases, ages 5-14, female
Fiji
41.1%
in 2021
Vanuatu
39.6%
in 2021
Fiji rank
88th
Vanuatu rank
90th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Fiji
- Vanuatu
How they compare
Fiji currently reports 41.1% against 39.6% in Vanuatu, a difference of 1.5%.
Across all 6 years both countries report, Fiji has been ahead every year.
Fiji ranks 88th and Vanuatu ranks 90th of 184 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.2% | 35.6% | 6.6% | Fiji |
| 2010s | 46.4% | 38.1% | 8.3% | Fiji |
| 2020s | 44.8% | 39.5% | 5.3% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Fiji or Vanuatu?
- Fiji, at 41.1% against 39.6% in Vanuatu as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Fiji and Vanuatu?
- 1.5%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Vanuatu?
- 6 years are reported by both, from 2000 to 2021.
- How do Fiji and Vanuatu rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Fiji ranks 88th and Vanuatu ranks 90th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.